@FiercePharma: Two most popular profiles from our Top 10 generics makers report: Teva and Sandoz | Follow @FiercePharma
@CarlyHFierce: Check out the top 10 DTC pharma advertisers from 2013 H1 in the new report. | Follow @CarlyHFierce
> Four Adcock Ingram investors say they're backing a $1.3 billion buyout offer from the Chilean drugmaker CFR Pharmaceuticals; the South African company's biggest shareholder, however, has said it would prefer a domestic owner. Report
> Cubist Pharmaceuticals ($CBST) won FDA approval for expanded use of Entereg, a drug used to speed healing after bowel surgery. Report
> The Finnish drugmaker Orion posted a 12% drop in operating profits for the quarter, to €67 million (about $92 million), thanks to generic competition for its Parkinson's drug. Report
> China's Guangxi Wuzhou Zhongheng Group posted a 29% increase in 9-month net profits to about $92 million. Report
> China's Jiangzhong Pharmaceuticals said its 9-month net profits had dropped 6.8% to 139.2 million yuan, or about $23 million. Report
> India's Symbiotec Pharmalab got a $48 million influx from the private equity firm Actis, which purchased a "significant" stake in the company. Report
@FierceMedDev: New special report: Top Med Tech Investments of Q3. Report | Follow @FierceMedDev
@MarkHFierce: For Boston Scientific, the first vaginal mesh implant lawsuits are slated to begin in March. Will the company settle? Item | Follow @MarkHFierce
@MichaelGFierce: Implantable, light-sensitive hydrogel could help treat diabetes. More from FierceDrugDelivery | Follow @MichaelGFierce
> Qiagen inks lung cancer diagnostics deal with Clovis Oncology. Story
> CareFusion's latest malfunction draws FDA's most serious label. Article
> European Parliament advances regs that would strengthen scrutiny of high-risk devices. News
> With FDA nod, Cardiovascular Systems targets $1.5B market. More
Biotech News
@FierceBiotech: ICYMI yesterday: 20 BigPharma and biotech mobile apps - 2013. Report | Follow @FierceBiotech
@JohnCFierce: Good thing we have archives--Pain surges after Pfizer commits to 3rd try for long-delayed pain drug Remoxy. Story | Follow @JohnCFierce
@DamianFierce: It's another Class I recall for CareFusion, and these things are starting to catch up with revenue, it seems. News | Follow @DamianFierce
> Novartis grabs an option to buy biotech startup for up to $300M. Story
> Gene therapy upstart launches with $50M and long-term commercial goals. More
> FDA gives J&J a thumbs-up--with a catch--on hep C drug simeprevir. Article
Biotech Research News
@EmilyMFierce: Stem cell-based therapy could be used to treat ALS, dementia. Story | Follow @EmilyMFierce
> Harvard, AstraZeneca partner to replace animal testing with 'organs-on-chips.' More
> Takeda, Hopkins developing new pancreatic cancer drugs. Story
> Novartis CDK 4/6 cancer drug effective in preclinical tests, advances to PhI. Item
> New approach could lead to universal flu vaccine. Article
> Mini pancreas grown in lab using mouse cells. Story
Pharma Manufacturing News
@EricPFierce: Is there a connection between pharma DTC spending and job cuts? In some cases, yes. FiercePharma special report | Follow @EricPFierce
> U.K. takes enforcement action against third Wockhardt plant. More
> Authorities seize large load of fake Xanax headed for Egypt. Story
> Teva API plant workers strike over wage gaps. Article
> German contract manufacturers invest €70 million on expansions. Item
> Teva opens $100M Croatia plant as it cuts elsewhere. Report
> Biocad taking biosimilar production to Brazil. More
And Finally... Want big hair? Researchers have found a new way to grow it, at least in mice. Report (sub. req.)